At a glance
ClinicalIndex Comparison RecordN/ACompleted· 4,719 enrolled
Drug / intervention
Shrunken Pore Syndromeother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Shrunken Pore Syndrome's Effect on Mortality in Elective Cardiac Surgery
In Brief
An observational study evaluating Shrunken Pore Syndrome for Kidney Diseases. Completed, enrolled 4,719 participants across 1 site.
Detailed Summary
To study the impact a difference in renal clearance of small and large molecules has on long-term survival.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsKidney Diseases
CountriesSweden
Collaborators--
Timeline
N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartJan 2010
Primary CompletionDec 2015
Study CompletionJan 2019
First PostedOct 2019
TodayJul 2026
First PostedOct 28, 2019
Enrollment StartJan 1, 2010
Primary CompletionDec 30, 2015
Study CompletionJan 10, 2019
TodayJul 2, 2026
Enrollment to primary: 6.0 yearsPosted 6.7 years ago
Interventions
Shrunken Pore Syndromeother
eGFR Cystatin C ≤ 60% of eGFR Creatinine